10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q3 2011

Filing Information

Form Type	10-Q
Accession Number	`0001104659-11-060466`
Period End Date	20110930
Filing Date	20111103
Fiscal Year	2011
Fiscal Period	Q3
XBRL Instance	cldx-20110930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 66 Cash Flow Statement 63

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.10M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$57.00M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.83M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$49.68M	USD	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$39.81M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$324.00K	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$204.00K	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	44.15M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	32.06M	shares	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.52M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	32.06M	shares	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.40M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	44.15M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$64.38M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$62.95M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$10.83M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$9.54M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$26.84M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$25.21M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$363.00K	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$348.00K	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Total Assets	`Assets`	$109.94M	USD	Point-in-time
Total Assets	`Assets`	$108.45M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$931.00K	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$457.00K	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$4.94M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$5.97M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$818.00K	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$264.00K	USD	Point-in-time
Current Portion of Term Loan	`SecuredDebtCurrent`	$1.11M	USD	Point-in-time
Current Portion of Term Loan	`SecuredDebtCurrent`	$4.09M	USD	Point-in-time
Convertible Subordinated Debt	`ConvertibleSubordinatedDebtCurrent`	$12.41M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$10.78M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$20.21M	USD	Point-in-time
Term Loan, less Current Portion	`SecuredLongTermDebt`	$8.89M	USD	Point-in-time
Term Loan, less Current Portion	`SecuredLongTermDebt`	$11.02M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$5.98M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$5.59M	USD	Point-in-time
Total Liabilities	`Liabilities`	$27.77M	USD	Point-in-time
Total Liabilities	`Liabilities`	$34.69M	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at September 30, 2011 and December 31, 2010	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at September 30, 2011 and December 31, 2010	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 44,147,214 and 32,055,382 Shares Issued and Outstanding at September 30, 2011 and December 31, 2010, respectively	`CommonStockValue`	$32.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 44,147,214 and 32,055,382 Shares Issued and Outstanding at September 30, 2011 and December 31, 2010, respectively	`CommonStockValue`	$44.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$232.68M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$270.25M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.65M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.75M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-192.27M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-160.21M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$80.67M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$75.25M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$108.45M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$109.94M	USD	Point-in-time

Income Statement 66 line items

Line Item	Tag	Value	Unit	Period
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$4.12M	USD	3 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$40.00K	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$1.37M	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$65.00K	USD	3 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$220.00K	USD	3 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$5.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$5.00K	USD	3 Qtrs
Product Royalties	`RoyaltyRevenue`	$2.32M	USD	1 Quarter
Product Royalties	`RoyaltyRevenue`	$6.76M	USD	3 Qtrs
Product Royalties	`RoyaltyRevenue`	$4.74M	USD	3 Qtrs
Product Royalties	`RoyaltyRevenue`	$1.04M	USD	1 Quarter
Total Revenue	`Revenues`	$6.83M	USD	3 Qtrs
Total Revenue	`Revenues`	$2.41M	USD	1 Quarter
Total Revenue	`Revenues`	$9.07M	USD	3 Qtrs
Total Revenue	`Revenues`	$2.36M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$7.21M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$8.59M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$22.61M	USD	3 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$20.91M	USD	3 Qtrs
Royalty	`RoyaltyExpense`	$2.32M	USD	1 Quarter
Royalty	`RoyaltyExpense`	$5.28M	USD	3 Qtrs
Royalty	`RoyaltyExpense`	$6.76M	USD	3 Qtrs
Royalty	`RoyaltyExpense`	$1.22M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$2.42M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$6.90M	USD	3 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$7.85M	USD	3 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$2.27M	USD	1 Quarter
Gain on Sale of Assets	`GainLossOnDispositionOfAssets`	$50.00K	USD	3 Qtrs
Gain on Sale of Assets	`GainLossOnDispositionOfAssets`	$50.00K	USD	3 Qtrs
Gain on Sale of Assets	`GainLossOnDispositionOfAssets`	$50.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$1.62M	USD	3 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$483.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$2.66M	USD	3 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$656.00K	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$36.64M	USD	3 Qtrs
Total Operating Expense	`CostsAndExpenses`	$11.29M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$37.85M	USD	3 Qtrs
Total Operating Expense	`CostsAndExpenses`	$13.84M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-27.57M	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-31.02M	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-8.88M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-11.48M	USD	1 Quarter
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$3.38M	USD	3 Qtrs
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$144.00K	USD	1 Quarter
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$307.00K	USD	3 Qtrs
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$124.00K	USD	1 Quarter
Interest Expense	`InterestExpense`	$1.00M	USD	3 Qtrs
Interest Expense	`InterestExpense`	$1.36M	USD	3 Qtrs
Interest Expense	`InterestExpense`	$332.00K	USD	1 Quarter
Interest Expense	`InterestExpense`	$438.00K	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-9.09M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.77M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-32.07M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-25.19M	USD	3 Qtrs
Basic and Diluted Net Loss Per Common Share (Note 4) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.28	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 4) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.79	USD	3 Qtrs
Basic and Diluted Net Loss Per Common Share (Note 4) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.27	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 4) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.85	USD	3 Qtrs
Shares Used in Calculating Basic Net Loss per Share (Note 4) (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	37.93M	shares	3 Qtrs
Shares Used in Calculating Basic Net Loss per Share (Note 4) (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	31.81M	shares	3 Qtrs
Shares Used in Calculating Basic Net Loss per Share (Note 4) (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	44.14M	shares	1 Quarter
Shares Used in Calculating Basic Net Loss per Share (Note 4) (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	31.92M	shares	1 Quarter
Shares Used in Calculating Diluted Net Loss per Share (Note 4) (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	31.92M	shares	1 Quarter
Shares Used in Calculating Diluted Net Loss per Share (Note 4) (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	31.81M	shares	3 Qtrs
Shares Used in Calculating Diluted Net Loss per Share (Note 4) (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.93M	shares	3 Qtrs
Shares Used in Calculating Diluted Net Loss per Share (Note 4) (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.14M	shares	1 Quarter

Cash Flow Statement 63 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-9.09M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.77M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-32.07M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-25.19M	USD	3 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.70M	USD	3 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$2.19M	USD	3 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$1.62M	USD	3 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$483.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$2.66M	USD	3 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$656.00K	USD	1 Quarter
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$96.00K	USD	3 Qtrs
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$89.00K	USD	3 Qtrs
Realized Loss on Sales and Maturities of Marketable Securities	`MarketableSecuritiesGainLoss`	$-22.00K	USD	3 Qtrs
Realized Loss on Sales and Maturities of Marketable Securities	`MarketableSecuritiesGainLoss`	$-5.00K	USD	3 Qtrs
Gain on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$58.00K	USD	3 Qtrs
Gain on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$11.00K	USD	3 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$1.70M	USD	3 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$2.20M	USD	3 Qtrs
Non-Cash Interest Expense	`AmortizationOfDebtDiscountPremium`	$250.00K	USD	3 Qtrs
Non-Cash Interest Expense	`AmortizationOfDebtDiscountPremium`	$546.00K	USD	3 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-88.00K	USD	3 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-120.00K	USD	3 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$108.00K	USD	3 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-58.00K	USD	3 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$-15.00K	USD	3 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$-554.00K	USD	3 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$556.00K	USD	3 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-2.14M	USD	3 Qtrs
Deferred Revenue	`IncreaseDecreaseInDeferredRevenue`	$-3.41M	USD	3 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.66M	USD	3 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-92.00K	USD	3 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-24.36M	USD	3 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-26.29M	USD	3 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$38.35M	USD	3 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$30.21M	USD	3 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$52.27M	USD	3 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$48.22M	USD	3 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$403.00K	USD	3 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.66M	USD	3 Qtrs
Proceeds from Sale or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$68.00K	USD	3 Qtrs
Proceeds from Sale or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$50.00K	USD	3 Qtrs
Net Cash Used in Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-10.20M	USD	3 Qtrs
Net Cash Used in Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-23.67M	USD	3 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$1.00M	USD	3 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$35.88M	USD	3 Qtrs
Issuance of Term Loan	`ProceedsFromIssuanceOfLongTermDebt`	$5.00M	USD	3 Qtrs
Payment of Convertible Subordinated Debt	`RepaymentsOfSubordinatedDebt`	$12.50M	USD	3 Qtrs
Payments of Other Long-Term Liabilities	`RepaymentsOfOtherLongTermDebt`	$72.00K	USD	3 Qtrs
Payments of Other Long-Term Liabilities	`RepaymentsOfOtherLongTermDebt`	$145.00K	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$28.30M	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$856.00K	USD	3 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$1.00K	USD	3 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-8.00K	USD	3 Qtrs
Net Decrease in Cash and Cash Equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-47.17M	USD	3 Qtrs
Net Decrease in Cash and Cash Equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-8.19M	USD	3 Qtrs
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$13.10M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$57.00M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$9.83M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$13.10M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$57.00M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$9.83M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.